Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.

Barney BM, Olivier KR, Miller RC, Haddock MG.

Radiat Oncol. 2012 May 3;7:67. doi: 10.1186/1748-717X-7-67.

2.

Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.

Torok J, Wegner RE, Burton SA, Heron DE.

Future Oncol. 2011 Jan;7(1):145-51. doi: 10.2217/fon.10.165. Review.

PMID:
21174545
3.

An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Wo JY, Dawson LA, Zhu AX, Hong TS.

Surg Oncol Clin N Am. 2014 Apr;23(2):353-68. doi: 10.1016/j.soc.2013.10.007. Epub 2013 Dec 7. Review.

PMID:
24560114
4.

Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma.

Ray CE Jr, Edwards A, Smith MT, Leong S, Kondo K, Gipson M, Rochon PJ, Gupta R, Messersmith W, Purcell T, Durham J.

J Vasc Interv Radiol. 2013 Aug;24(8):1218-26. doi: 10.1016/j.jvir.2013.03.019. Epub 2013 May 28. Review.

PMID:
23725793
5.

Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.

Almaghrabi MY, Supiot S, Paris F, Mahé MA, Rio E.

Radiat Oncol. 2012 Aug 1;7:126. doi: 10.1186/1748-717X-7-126. Review.

6.

Radiation therapy in cholangiocellular carcinomas.

Brunner TB, Seufferlein T.

Best Pract Res Clin Gastroenterol. 2016 Aug;30(4):593-602. doi: 10.1016/j.bpg.2016.08.003. Epub 2016 Aug 24. Review.

PMID:
27644907

Supplemental Content

Support Center